ACTA1 and Bloom syndrome: Western blot analysis showed a significant up‐regulation of Collagen I and α‐SMA expression in the BLM group, while mm102 treatment resulted in decreased α‐SMA and H3K4me3 levels, along with a downward trend in PU.1 and Collagen I expression (Figure 6D,E).